Insulin inhibits IGFBP-1 synthesis in liver and other tissue, and this may be one key mechanism through which insulin increases endometrial cancer risk (Brismar et al, 1994; Lee et al, 1997). This evidence concerns the gene IGFBP1 and endometrial cancer.